Clare Bowie, a British woman who suffered paralysis after receiving the AstraZeneca COVID-19 vaccine, has spoken out against the United Kingdom’s Vaccine Damage Payment Scheme (VDPS) for its inadequate compensation.
Despite qualifying for the scheme, Bowie received a payout of £120,000 ($152,640), which she considers insufficient to cover the costs associated with her severe disability.
The VDPS, established in 1979, provides financial compensation to individuals adversely affected by vaccines, but Bowie argues that the payout should be adjusted for inflation and scaled based on the extent of disability.
Clare Bowie’s experience highlights the challenges faced by individuals who suffer vaccine injuries and the shortcomings of compensation schemes. After being injected with the AstraZeneca COVID-19 vaccine, Bowie developed a mysterious spreading paralysis that left her paralyzed from the chest down. While initially misdiagnosed, she was later diagnosed with acute disseminated encephalitis complicated by transverse myelitis (ADEM), a rare condition causing inflammation in the brain and spinal cord.
Bowie’s case raises concerns about the long-term effects of COVID-19 vaccines and the need for comprehensive support for those who experience adverse reactions. The VDPS, designed to provide financial compensation to vaccine-damaged individuals, is criticized for its outdated payment amount of £120,000 ($152,640),